Table 3.
Sevoflurane (n = 14) |
Propofol (n = 14) |
P | |
---|---|---|---|
mBP (mmHg) | |||
T1: control | 87 ± 9 | 87 ± 21 | 0.74 |
T2: intubation | 75 ± 13 | 70 ± 12 | 0.42 |
T3: lateral | 79 ± 17 | 71 ± 14 | 0.16 |
T4: lateral 1 h | 76 ± 12 | 78 ± 13 | 0.68 |
T5: supine | 82 ± 13 | 79 ± 17 | 0.63 |
Heart rate (bpm) | |||
T1 | 75 ± 23 | 72 ± 13 | 0.64 |
T2 | 68 ± 22 | 71 ± 14 | 0.61 |
T3 | 67 ± 17 | 71 ± 14 | 0.52 |
T4 | 72 ± 14 | 77 ± 11 | 0.43 |
T5 | 73 ± 15 | 75 ± 11 | 0.68 |
ETCO2 (mmHg) | |||
T1 | 27 ± 6 | 31 ± 6 | 0.07 |
T2 | 32 ± 6 | 34 ± 6 | 0.26 |
T3 | 36 ± 3 | 32 ± 6 | 0.07 |
T4 | 34 ± 5 | 34 ± 6 | 0.81 |
T5 | 34 ± 6 | 34 ± 6 | 0.87 |
Data are shown as mean ± SD. There was no difference in mBP, heart rate and ETCO2 between the sevoflurane and propofol groups at any time point